|
hsa05206
|
MicroRNAs in cancer
|
0.00000602
|
9
|
MCL1/CDC25A/NOTCH2/BCL2L2/VEGFA/CDKN1A/KIF23/SOX4/TIMP3
|
|
hsa04110
|
Cell cycle
|
0.0000297
|
6
|
CDC25A/WEE1/CHEK1/CDKN1A/E2F5/YWHAH
|
|
hsa01522
|
Endocrine resistance
|
0.00011607
|
5
|
NCOA3/CDKN1A/MAPK9/JAG1/NOTCH2
|
|
hsa04114
|
Oocyte meiosis
|
0.00027439
|
5
|
PPP3R1/BTRC/ITPR1/YWHAH/CPEB3
|
|
hsa05200
|
Pathways in cancer
|
0.00056634
|
8
|
RASGRP1/RUNX1T1/VEGFA/CDKN1A/GNB5/HIF1A/MAPK9/LAMC1
|
|
hsa04010
|
MAPK signaling pathway
|
0.00132625
|
6
|
PPP3R1/RASGRP1/DUSP2/MAP3K1/MAPK9/MEF2C
|
|
hsa05202
|
Transcriptional misregulation in cancer
|
0.00157405
|
5
|
CDKN1A/RUNX1T1/MEF2C/HOXA10/PBX3
|
|
hsa05205
|
Proteoglycans in cancer
|
0.0029711
|
5
|
CDKN1A/ITPR1/TIMP3/VEGFA/HIF1A
|
|
hsa04115
|
p53 signaling pathway
|
0.00438531
|
3
|
CDKN1A/CHEK1/RRM2
|
|
hsa04151
|
PI3K-Akt signaling pathway
|
0.00536491
|
6
|
VEGFA/MCL1/CDKN1A/GNB5/YWHAH/LAMC1
|
|
hsa04921
|
Oxytocin signaling pathway
|
0.00681985
|
4
|
CDKN1A/PPP3R1/ITPR1/MEF2C
|
|
hsa05166
|
HTLV-I infection
|
0.00730939
|
5
|
CDKN1A/PPP3R1/MAP3K1/CHEK1/TP53INP1
|
|
hsa04320
|
Dorso-ventral axis formation
|
0.00825292
|
2
|
CPEB3/NOTCH2
|
|
hsa04710
|
Circadian rhythm
|
0.00935463
|
2
|
BTRC/CRY2
|
|
hsa04912
|
GnRH signaling pathway
|
0.00943716
|
3
|
MAP3K1/ITPR1/MAPK9
|
|
hsa04914
|
Progesterone mediated oocyte maturation
|
0.0108457
|
3
|
MAPK9/CPEB3/CDC25A
|
|
hsa04723
|
Retrograde endocannabinoid signaling
|
0.01205547
|
3
|
ITPR1/MAPK9/GNB5
|
|
hsa04066
|
HIF-1 signaling pathway
|
0.01333979
|
3
|
CDKN1A/HIF1A/VEGFA
|
|
hsa04660
|
T cell receptor signaling pathway
|
0.01401011
|
3
|
PPP3R1/RASGRP1/MAPK9
|
|
hsa05219
|
Bladder cancer
|
0.01648587
|
2
|
CDKN1A/VEGFA
|
|
hsa04724
|
Glutamatergic synapse
|
0.01688062
|
3
|
PPP3R1/ITPR1/GNB5
|
|
hsa04919
|
Thyroid hormone signaling pathway
|
0.01923358
|
3
|
NCOA3/HIF1A/NOTCH2
|
|
hsa04330
|
Notch signaling pathway
|
0.02190805
|
2
|
JAG1/NOTCH2
|
|
hsa04728
|
Dopaminergic synapse
|
0.0226392
|
3
|
ITPR1/MAPK9/GNB5
|
|
hsa04014
|
Ras signaling pathway
|
0.0227743
|
4
|
RASGRP1/VEGFA/MAPK9/GNB5
|
|
hsa04380
|
Osteoclast differentiation
|
0.02445721
|
3
|
PPP3R1/OSCAR/MAPK9
|
|
hsa04068
|
FoxO signaling pathway
|
0.02539501
|
3
|
CDKN1A/GABARAPL1/MAPK9
|
|
hsa04210
|
Apoptosis
|
0.02882821
|
3
|
MAPK9/ITPR1/MCL1
|
|
hsa04310
|
Wnt signaling pathway
|
0.02882821
|
3
|
PPP3R1/BTRC/MAPK9
|
|
hsa05161
|
Hepatitis B
|
0.03195714
|
3
|
CDKN1A/MAP3K1/MAPK9
|
|
hsa04370
|
VEGF signaling pathway
|
0.03660229
|
2
|
PPP3R1/VEGFA
|
|
hsa04924
|
Renin secretion
|
0.03660229
|
2
|
PPP3R1/ITPR1
|
|
hsa05131
|
Shigellosis
|
0.03864514
|
2
|
BTRC/MAPK9
|
|
hsa04720
|
Long-term potentiation
|
0.03864514
|
2
|
PPP3R1/ITPR1
|
|
hsa05212
|
Pancreatic cancer
|
0.04073055
|
2
|
VEGFA/MAPK9
|
|
hsa05211
|
Renal cell carcinoma
|
0.04178893
|
2
|
HIF1A/VEGFA
|
|
hsa04622
|
RIG-I-like receptor signaling pathway
|
0.0428576
|
2
|
MAP3K1/MAPK9
|
|
hsa04141
|
Protein processing in endoplasmic reticulum
|
0.0429848
|
3
|
MAPK9/TRAM1/PDIA6
|
|
hsa04022
|
cGMP-PKG signaling pathway
|
0.04681452
|
3
|
PPP3R1/ITPR1/MEF2C
|
|
hsa04260
|
Cardiac muscle contraction
|
0.04835144
|
2
|
TPM2/SLC9A6
|
